Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 58,131 $ 31,983
Short-term investments 13,468 48,214
Accounts receivable, net 12,597 9,185
Inventories 81,159 71,202
Contract assets 15,901 6,805
Prepaid expenses and other current assets 2,515 5,533
Total current assets 183,771 172,922
Property and equipment, net 17,430 19,812
Equipment on lease, net 7,020 9,070
Other assets 21,782 23,310
Total assets 230,003 225,114
Current liabilities:    
Accounts payable 13,135 12,207
Accrued expenses and other current liabilities 11,215 15,877
Debt – current portion 52,211 2,775
Debt derivatives 17,538  
Contract liabilities 4,847 15,194
Total current liabilities 98,946 46,053
Long-term debt – less current portion 0 5,422
Contingent earnout liabilities 14,414 17,414
Warrant liabilities 2,883 2,745
Other noncurrent liabilities 10,805 12,634
Total liabilities 127,048 84,268
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Common stock, $0.00001 par value - 500,000,000 shares authorized at September 30, 2023 and December 31, 2022, 200,314,984 and 187,561,368 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively 2 2
Additional paid-in capital 399,847 361,528
Accumulated other comprehensive loss (252) (837)
Accumulated deficit (296,642) (219,847)
Total stockholders’ equity 102,955 140,846
Total liabilities and stockholders’ equity $ 230,003 $ 225,114